What is the Pediatric Drugs Market?

The Pediatric Drugs Market refers to the pharmaceutical sector focused on developing, manufacturing, and distributing medications specifically designed for children, from infancy to adolescence.

How big is the Pediatric Drugs Market?

The global Pediatric Drugs Market size was estimated at USD 28.8 Billion in 2023 and is expected to reach USD 95.4 Billion in 2033.

What is the Pediatric Drugs Market growth?

The global Pediatric Drugs Market is expected to grow at a compound annual growth rate of 12.7%. From 2024 To 2033

Who are the key companies/players in the Pediatric Drugs Market?

Some of the key players in the Pediatric Drugs Markets are Horizon Therapeutics Plc.,Jazz Pharmaceuticals, Inc., Gilead Sciences, Inc., Biomarin Pharmaceutical, Inc., Sanofi, AstraZeneca, Cipla, Inc., Apotex Inc., Endo international Plc., Bayer AG, Sun Pharmaceuticals, Inc., Novartis AG, Hikma Pharmaceuticals Plc.

Why is the Pediatric Drugs Market important?

The Pediatric Drugs Market plays a crucial role in addressing the unique healthcare needs of children, ensuring access to safe and effective medications tailored to their age, weight, and developmental stage.

What are the key therapeutic areas covered in the Pediatric Drugs Market?

Key therapeutic areas in the Pediatric Drugs Market include infectious diseases, respiratory conditions, neurological disorders, oncology, gastrointestinal disorders, and rare genetic diseases prevalent in children.

What are the future trends in the Pediatric Drugs Market?

Future trends in the Pediatric Drugs Market include the development of innovative pediatric formulations, increased emphasis on pediatric pharmacogenomics, expansion of pediatric drug repurposing initiatives, and advancements in pediatric clinical trial design.

Global Pediatric Drugs Market, By Type (Respiratory disorder drugs, Autoimmune disorder drugs, Gastrointestinal drugs, Cardiovascular drugs), By Route of Administration (Oral, Topical, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Published date: June 2024
Report ID: 116521
Number of Pages: 344
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Paediatric Drugs Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Paediatric Drugs Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Paediatric Drugs Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-Economic Factors/Geopolitical Factors
- 3. Global Paediatric Drugs Market Analysis and Forecast, By Segment, 2024-2033
  - 3.1. Key Findings
  - 3.2. Global Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2024-2033
  - 3.3. Global Paediatric Drugs Market Attractiveness Analysis, By Type
    
    3.3.1. Respiratory disorder drugs
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Autoimmune disorder drugs
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
    
    3.3.3. Gastrointestinal drugs
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
    
    3.3.4. Cardiovascular drugs
    
    3.3.4.1. Insights
    
    3.3.4.2. Key Takeaways
  - 3.4. Global Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2024-2033
  - 3.5. Global Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
    
    3.5.1. Oral
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Topical
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Parenteral
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Others
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
  - 3.6. Global Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2024-2033
  - 3.7. Global Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
    
    3.7.1. Hospital Pharmacy
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Retail Pharmacy
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Online Pharmacy
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
- 4. Global Paediatric Drugs Market Analysis and Forecast, By Region, 2024-2033
  - 4.1. Key Findings
  - 4.2. Global Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2024-2033
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Paediatric Drugs Market Attractiveness Analysis, By Region
- 5. North America Paediatric Drugs Market Analysis and Forecast, 2024-2033
  - 5.1. Key Findings
  - 5.2. North America Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2024-2033
  - 5.3. North America Paediatric Drugs Market Attractiveness Analysis, By Type
  - 5.4. North America Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2024-2033
  - 5.5. North America Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
  - 5.6. North America Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2024-2033
  - 5.7. North America Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
  - 5.8. North America Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 5.9. North America Paediatric Drugs Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Paediatric Drugs Market Analysis and Forecast, 2024-2033
  - 6.1. Key Findings
  - 6.2. Europe Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2024-2033
  - 6.3. Europe Paediatric Drugs Market Attractiveness Analysis, By Type
  - 6.4. Europe Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2024-2033
  - 6.5. Europe Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
  - 6.6. Europe Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2024-2033
  - 6.7. Europe Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
  - 6.8. Europe Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 6.9. Europe Paediatric Drugs Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherlands
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Paediatric Drugs Market Analysis and Forecast, 2024-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2024-2033
  - 7.3. Asia Pacific Paediatric Drugs Market Attractiveness Analysis, By Type
  - 7.4. Asia Pacific Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2024-2033
  - 7.5. Asia Pacific Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
  - 7.6. Asia Pacific Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2024-2033
  - 7.7. Asia Pacific Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
  - 7.8. Asia Pacific Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 7.9. Asia Pacific Paediatric Drugs Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. New Zealand
    
    7.9.6. Singapore
    
    7.9.7. Thailand
    
    7.9.8. Vietnam
    
    7.9.9. Rest of Asia Pacific
- 8. Latin America Paediatric Drugs Market Analysis and Forecast, 2024-2033
  - 8.1. Key Findings
  - 8.2. Latin America Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2024-2033
  - 8.3. Latin America Paediatric Drugs Market Attractiveness Analysis, By Type
  - 8.4. Latin America Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2024-2033
  - 8.5. Latin America Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
  - 8.6. Latin America Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2024-2033
  - 8.7. Latin America Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
  - 8.8. Latin America Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 8.9. Latin America Paediatric Drugs Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Paediatric Drugs Market Analysis and Forecast, 2024-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2024-2033
  - 9.3. Middle East & Africa Paediatric Drugs Market Attractiveness Analysis, By Type
  - 9.4. Middle East & Africa Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2024-2033
  - 9.5. Middle East & Africa Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
  - 9.6. Middle East & Africa Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2024-2033
  - 9.7. Middle East & Africa Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
  - 9.8. Middle East & Africa Paediatric Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 9.9. Middle East & Africa Paediatric Drugs Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
  - 10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Horizon Therapeutics Plc.
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Jazz Pharmaceutical Inc.
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Gilead Sciences, Inc.
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Biomarin Pharmaceutical, Inc.
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. Sanofi
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. AstraZeneca
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Cipla, Inc.
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Apotex, Inc.
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Endo International, Plc.
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Bayer AG
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
    
    10.7.11. Sun Pharmaceuticals Inc.
    
    10.7.11.1. Company Details
    
    10.7.11.2. Business Overview
    
    10.7.11.3. Product Portfolio
    
    10.7.11.4. Financial Insights
    
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.11.6. SWOT Analysis
    
    10.7.11.7. Geographic Footprint
    
    10.7.12. Novartis AG
    
    10.7.12.1. Company Details
    
    10.7.12.2. Business Overview
    
    10.7.12.3. Product Portfolio
    
    10.7.12.4. Financial Insights
    
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.12.6. SWOT Analysis
    
    10.7.12.7. Geographic Footprint
    
    10.7.13. Hikma Pharmaceuticals, Inc.
    
    10.7.13.1. Company Details
    
    10.7.13.2. Business Overview
    
    10.7.13.3. Product Portfolio
    
    10.7.13.4. Financial Insights
    
    10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.13.6. SWOT Analysis
    
    10.7.13.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 2. Global Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 3. Global Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 4. Global Paediatric Drugs Market Value (US$ Mn), By Region, 2024-2033
- Table 5. North America Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 6. North America Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 7. North America Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 8. North America Paediatric Drugs Market Value (US$ Mn), By Country, 2024-2033
- Table 9. The US Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 10. The US Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 11. The US Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 12. Canada Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 13. Canada Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 14. Canada Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 15. Europe Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 16. Europe Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 17. Europe Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 18. Europe Paediatric Drugs Market Value (US$ Mn), By Country, 2024-2033
- Table 19. Germany Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 20. Germany Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 21. Germany Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 22. The UK Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 23. The UK Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 24. The UK Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 25. France Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 26. France Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 27. France Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 28. Spain Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 29. Spain Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 30. Spain Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 31. Italy Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 32. Italy Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 33. Italy Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 34. Russia Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 35. Russia Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 36. Russia Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 37. Netherlands Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 38. Netherlands Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 39. Netherlands Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 40. Rest of Europe Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 41. Rest of Europe Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 42. Rest of Europe Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 43. Asia Pacific Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 44. Asia Pacific Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 45. Asia Pacific Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 46. Asia Pacific Paediatric Drugs Market Value (US$ Mn), By Country, 2024-2033
- Table 47. China Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 48. China Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 49. China Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 50. India Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 51. Global Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 52. Global Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 53. Japan Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 54. Japan Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 55. Japan Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 56. South Korea Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 57. South Korea Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 58. South Korea Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 59. New Zealand Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 60. New Zealand Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 61. New Zealand Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 62. Singapore Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 63. Singapore Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 64. Singapore Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 65. Thailand Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 66. Thailand Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 67. Thailand Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 68. Vietnam Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 69. Vietnam Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 70. Vietnam Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 71. Rest of Asia Pacific Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 72. Rest of Asia Pacific Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 73. Rest of Asia Pacific Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 74. Latin America Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 75. Latin America Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 76. Latin America Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 77. Latin America Paediatric Drugs Market Value (US$ Mn), By Country, 2024-2033
- Table 78. Brazil Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 79. Brazil Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 80. Brazil Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 81. Mexico Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 82. Mexico Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 83. Mexico Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 84. Rest of Latin America Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 85. Rest of Latin America Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 86. Rest of Latin America Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 87. Middle East & Africa Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 88. Middle East & Africa Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 89. Middle East & Africa Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 90. Middle East & Africa Paediatric Drugs Market Value (US$ Mn), By Country, 2024-2033
- Table 91. South Africa Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 92. South Africa Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 93. South Africa Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 94. Saudi Arabia Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 95. Saudi Arabia Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 96. Saudi Arabia Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 97. UAE Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 98. UAE Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 99. UAE Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
- Table 100. Rest of Middle East & Africa Paediatric Drugs Market Value (US$ Mn), By Type, 2024-2033
- Table 101. Rest of Middle East & Africa Paediatric Drugs Market Value (US$ Mn), By Route of Administration, 2024-2033
- Table 102. Rest of Middle East & Africa Paediatric Drugs Market Value (US$ Mn), By Distribution Channel, 2024-2033
List of Figures
- Figure 1. Global Paediatric Drugs Market Snapshot: Market Value (US$ Mn), 2024-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Paediatric Drugs Market
- Figure 5. Global Paediatric Drugs Market Analysis, By Type, 2018, 2023 and 2033
- Figure 6. Global Paediatric Drugs Market Attractiveness Analysis, By Type
- Figure 7. Global Paediatric Drugs Market Analysis, By Route of Administration, 2018, 2023 and 2033
- Figure 8. Global Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 9. Global Paediatric Drugs Market Analysis, By Distribution Channel, 2018, 2023 and 2033
- Figure 10. Global Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 11. North America Paediatric Drugs Market Analysis, By Type, 2018, 2023 and 2033
- Figure 12. North America Paediatric Drugs Market Attractiveness Analysis, By Type
- Figure 13. North America Paediatric Drugs Market (US$ Mn), by Respiratory disorder drugs, 2024-2033
- Figure 14. North America Paediatric Drugs Market (US$ Mn), by Autoimmune disorder drugs, 2024-2033
- Figure 15. North America Paediatric Drugs Market (US$ Mn), by Gastrointestinal drugs, 2024-2033
- Figure 16. North America Paediatric Drugs Market (US$ Mn), by Cardiovascular drugs, 2024-2033
- Figure 17. North America Paediatric Drugs Market Analysis, By Route of Administration, 2018, 2023 and 2033
- Figure 18. North America Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 19. North America Paediatric Drugs Market (US$ Mn), by Oral, 2024-2033
- Figure 20. North America Paediatric Drugs Market (US$ Mn), by Topical, 2024-2033
- Figure 21. North America Paediatric Drugs Market (US$ Mn), by Parenteral, 2024-2033
- Figure 22. North America Paediatric Drugs Market (US$ Mn), by Others, 2024-2033
- Figure 23. North America Paediatric Drugs Market Analysis, By Distribution Channel, 2018, 2023 and 2033
- Figure 24. North America Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 25. North America Paediatric Drugs Market (US$ Mn), by Hospital Pharmacy, 2024-2033
- Figure 26. North America Paediatric Drugs Market (US$ Mn), by Retail Pharmacy, 2024-2033
- Figure 27. North America Paediatric Drugs Market (US$ Mn), by Online Pharmacy, 2024-2033
- Figure 28. North America Paediatric Drugs Market Analysis, By Country, 2018, 2023 and 2033
- Figure 29. North America Paediatric Drugs Market Attractiveness Analysis, By Country
- Figure 30. Europe Paediatric Drugs Market Analysis, By Type, 2018, 2023 and 2033
- Figure 31. Europe Paediatric Drugs Market Attractiveness Analysis, By Type
- Figure 32. Europe Paediatric Drugs Market (US$ Mn), by Respiratory disorder drugs, 2024-2033
- Figure 33. Europe Paediatric Drugs Market (US$ Mn), by Autoimmune disorder drugs, 2024-2033
- Figure 34. Europe Paediatric Drugs Market (US$ Mn), by Gastrointestinal drugs, 2024-2033
- Figure 35. Europe Paediatric Drugs Market (US$ Mn), by Cardiovascular drugs, 2024-2033
- Figure 36. Europe Paediatric Drugs Market Analysis, By Route of Administration, 2018, 2023 and 2033
- Figure 37. Europe Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 38. Europe Paediatric Drugs Market (US$ Mn), by Oral, 2024-2033
- Figure 39. Europe Paediatric Drugs Market (US$ Mn), by Topical, 2024-2033
- Figure 40. Europe Paediatric Drugs Market (US$ Mn), by Parenteral, 2024-2033
- Figure 41. Europe Paediatric Drugs Market (US$ Mn), by Others, 2024-2033
- Figure 42. Europe Paediatric Drugs Market Analysis, By Distribution Channel, 2018, 2023 and 2033
- Figure 43. Europe Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 44. Europe Paediatric Drugs Market (US$ Mn), by Hospital Pharmacy, 2024-2033
- Figure 45. Europe Paediatric Drugs Market (US$ Mn), by Retail Pharmacy, 2024-2033
- Figure 46. Europe Paediatric Drugs Market (US$ Mn), by Online Pharmacy, 2024-2033
- Figure 47. Europe Paediatric Drugs Market Analysis, By Country, 2018, 2023 and 2033
- Figure 48. Europe Paediatric Drugs Market Attractiveness Analysis, By Country
- Figure 49. Asia Pacific Paediatric Drugs Market Analysis, By Type, 2018, 2023 and 2033
- Figure 50. Asia Pacific Paediatric Drugs Market Attractiveness Analysis, By Type
- Figure 51. Asia Pacific Paediatric Drugs Market (US$ Mn), by Respiratory disorder drugs, 2024-2033
- Figure 52. Asia Pacific Paediatric Drugs Market (US$ Mn), by Autoimmune disorder drugs, 2024-2033
- Figure 53. Asia Pacific Paediatric Drugs Market (US$ Mn), by Gastrointestinal drugs, 2024-2033
- Figure 54. Asia Pacific Paediatric Drugs Market (US$ Mn), by Cardiovascular drugs, 2024-2033
- Figure 55. Asia Pacific Paediatric Drugs Market Analysis, By Route of Administration, 2018, 2023 and 2033
- Figure 56. Asia Pacific Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 57. Asia Pacific Paediatric Drugs Market (US$ Mn), by Oral, 2024-2033
- Figure 58. Asia Pacific Paediatric Drugs Market (US$ Mn), by Topical, 2024-2033
- Figure 59. Asia Pacific Paediatric Drugs Market (US$ Mn), by Parenteral, 2024-2033
- Figure 60. Asia Pacific Paediatric Drugs Market (US$ Mn), by Others, 2024-2033
- Figure 61. Asia Pacific Paediatric Drugs Market Analysis, By Distribution Channel, 2018, 2023 and 2033
- Figure 62. Asia Pacific Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 63. Asia Pacific Paediatric Drugs Market (US$ Mn), by Hospital Pharmacy, 2024-2033
- Figure 64. Asia Pacific Paediatric Drugs Market (US$ Mn), by Retail Pharmacy, 2024-2033
- Figure 65. Asia Pacific Paediatric Drugs Market (US$ Mn), by Online Pharmacy, 2024-2033
- Figure 66. Asia Pacific Paediatric Drugs Market Analysis, By Country, 2018, 2023 and 2033
- Figure 67. Asia Pacific Paediatric Drugs Market Attractiveness Analysis, By Country
- Figure 68. Latin America Paediatric Drugs Market Analysis, By Type, 2018, 2023 and 2033
- Figure 69. Latin America Paediatric Drugs Market Attractiveness Analysis, By Type
- Figure 70. Latin America Paediatric Drugs Market (US$ Mn), by Respiratory disorder drugs, 2024-2033
- Figure 71. Latin America Paediatric Drugs Market (US$ Mn), by Autoimmune disorder drugs, 2024-2033
- Figure 72. Latin America Paediatric Drugs Market (US$ Mn), by Gastrointestinal drugs, 2024-2033
- Figure 73. Latin America Paediatric Drugs Market (US$ Mn), by Cardiovascular drugs, 2024-2033
- Figure 74. Latin America Paediatric Drugs Market Analysis, By Route of Administration, 2018, 2023 and 2033
- Figure 75. Latin America Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 76. Latin America Paediatric Drugs Market (US$ Mn), by Oral, 2024-2033
- Figure 77. Latin America Paediatric Drugs Market (US$ Mn), by Topical, 2024-2033
- Figure 78. Latin America Paediatric Drugs Market (US$ Mn), by Parenteral, 2024-2033
- Figure 79. Latin America Paediatric Drugs Market (US$ Mn), by Others, 2024-2033
- Figure 80. Latin America Paediatric Drugs Market Analysis, By Distribution Channel, 2018, 2023 and 2033
- Figure 81. Latin America Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 82. Latin America Paediatric Drugs Market (US$ Mn), by Hospital Pharmacy, 2024-2033
- Figure 83. Latin America Paediatric Drugs Market (US$ Mn), by Retail Pharmacy, 2024-2033
- Figure 84. Latin America Paediatric Drugs Market (US$ Mn), by Online Pharmacy, 2024-2033
- Figure 85. Latin America Paediatric Drugs Market Analysis, By Country, 2018, 2023 and 2033
- Figure 86. Latin America Paediatric Drugs Market Attractiveness Analysis, By Country
- Figure 87. Middle East & Africa Paediatric Drugs Market Analysis, By Type, 2018, 2023 and 2033
- Figure 88. Middle East & Africa Paediatric Drugs Market Attractiveness Analysis, By Type
- Figure 89. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Respiratory disorder drugs, 2024-2033
- Figure 90. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Autoimmune disorder drugs, 2024-2033
- Figure 91. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Gastrointestinal drugs, 2024-2033
- Figure 92. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Cardiovascular drugs, 2024-2033
- Figure 93. Middle East & Africa Paediatric Drugs Market Analysis, By Route of Administration, 2018, 2023 and 2033
- Figure 94. Middle East & Africa Paediatric Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 95. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Oral, 2024-2033
- Figure 96. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Topical, 2024-2033
- Figure 97. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Parenteral, 2024-2033
- Figure 98. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Others, 2024-2033
- Figure 99. Middle East & Africa Paediatric Drugs Market Analysis, By Distribution Channel, 2018, 2023 and 2033
- Figure 100. Middle East & Africa Paediatric Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 101. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Hospital Pharmacy, 2024-2033
- Figure 102. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Retail Pharmacy, 2024-2033
- Figure 103. Middle East & Africa Paediatric Drugs Market (US$ Mn), by Online Pharmacy, 2024-2033
- Figure 104. Middle East & Africa Paediatric Drugs Market Analysis, By Country, 2018, 2023 and 2033
- Figure 105. Middle East & Africa Paediatric Drugs Market Attractiveness Analysis, By Country
- Horizon Therapeutics Plc.
- Jazz Pharmaceuticals, Inc.
- Gilead Sciences, Inc.
- Biomarin Pharmaceutical, Inc.
- Sanofi Company Profile
- AstraZeneca Plc Company Profile
- Cipla, Inc.
- Apotex Inc.
- Endo international Plc.
- Bayer AG Company Profile
- Sun Pharmaceuticals, Inc.
- Novartis AG Company Profile
- Hikma Pharmaceuticals Plc.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 116521
Published Date June 2024
Rating
- ★★★★★
  
  ★★★★★
- (49)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)